Hi JT.
Glad to hear from you.
Well if you want to talk shop:
Current possibilities are IDMI (@$2.76) and ZIXI (@$2.01). I also hold AXTI, which has had a recent run-up, but long term AXTI could do very well.
IDMI, jr. biotech. 27.5 million shares. Short term all or nothing on Junovan approval by FDA. in late August. If yes, >$7 in days. If no, pipeline, which is impressive, but a $3 stock for many months. I have a large position in IDMI @$3.18, currently in big hole. Watching, waiting and praying.
ZIXI. 60 milion shares. I just bought ZIXI on Tuesday @$1.88. Email security (main source of revenue now) and eprescription (possible future revenue source). Turn around story. Possible positive EPS in late 2008.
Long term looks very good, 5 year projected growth 40%, (www.yahoo.com). Short term some very strange things are in play. Apparently there is a huge nake short position in this stock. Per recent SEC ruling all "grandfathered" nake short positions must closed by 10/8/08. Holding ZIXI for long term.
Cheers.